BioWorld MedTech

Aug. 26, 2010

Canaccord analyst sees robust M&A trends in cardio

The cardiovascular device sector should expect to see M&A activity to be more robust in the next couple of years than it has been in the last 20 to 30 years, according to one analyst who covers this space. (Medical Device Daily) Read More

F&S analyst: Device misuse key in causing medical errors

International report: Elekta's Gamma Knife used for the first time in Australia

Washington roundup: FDA seeks input on four pre-amendments devices

Financings roundup: Healthsense closes growth capital funding round

Deals roundup: Stryker in move to acquire Gaymar for nearly $150M

People in the News

Agreements/contracts: Cerus acquires rights to BioOne's Intercept

Grants roundup: Dynasil company wins $6.2M in DoE grants

Product Briefs

Patent watch: Celera gets gene-detecting patent for heart attack risk

MDD's Ortho Extra

MDD's food for med-tech thought

Today's news in brief

BioWorld

BioWorld briefs for Dec. 17, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 17, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

European Commission floats multiple fixes for MDR, IVDR

BioWorld MedTech

The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...

Decorative scales of justice in a courtroom

DOJ arrests shed light on Medicare skin substitute controversy

BioWorld MedTech

Much has been made of the recent skyrocketing of Medicare spending on skin substitutes, but a new enforcement action by the U.S. Department of Justice might help...